Loeb Partners Corp’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-10,800
Closed -$642K 166
2018
Q4
$642K Hold
10,800
0.3% 74
2018
Q3
$724K Sell
10,800
-2,000
-16% -$133K 0.27% 76
2018
Q2
$830K Buy
+12,800
New +$837K 0.21% 99
2018
Q1
Sell
-10,800
Closed -$815K 126
2017
Q4
$815K Hold
10,800
0.24% 86
2017
Q3
$787K Sell
10,800
-2,000
-16% -$144K 0.24% 91
2017
Q2
$949K Hold
12,800
0.27% 86
2017
Q1
$937K Hold
12,800
0.28% 81
2016
Q4
$838K Hold
12,800
0.28% 79
2016
Q3
$949K Hold
12,800
0.34% 74
2016
Q2
$937K Hold
12,800
0.31% 73
2016
Q1
$904K Hold
12,800
0.32% 70
2015
Q4
$853K Hold
12,800
0.27% 74
2015
Q3
$812K Hold
12,800
0.3% 77
2015
Q2
$837K Sell
12,800
-29,860
-70% -$2.03M 0.24% 88
2015
Q1
$2.96M Hold
42,660
0.87% 33
2014
Q4
$2.95M Sell
42,660
-6,350
-13% -$429K 0.88% 32
2014
Q3
$3.2M Sell
49,010
-2,000
-4% -$132K 1.06% 31
2014
Q2
$3.48M Sell
51,010
-4,000
-7% -$268K 1.06% 32
2014
Q1
$3.57M Buy
55,010
+38,210
+227% +$2.41M 1.2% 25
2013
Q4
$1.1M Hold
16,800
0.35% 78
2013
Q3
$996K Hold
16,800
0.34% 80
2013
Q2
$962K Buy
+16,800
New +$997K 0.35% 74

Other funds holding CL

Loeb Partners Corp's CL Position: Q1 2019 in Review

Loeb Partners Corp sold out of Colgate-Palmolive (CL) in Q1 2019, closing a stake of 10,800 shares — an estimated $642K sold.

Loeb Partners Corp first reported a position in CL in Q2 2013 and held it in 22 quarters. The position peaked at $3.57M in Q1 2014. 1,446 funds tracked by Wall St. Rank hold CL as of Q1 2019.

  • Loeb Partners Corp reported no remaining Colgate-Palmolive position as of Q1 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 10,800 Colgate-Palmolive shares in Q1 2019, an estimated $642K.
  • Loeb Partners Corp first reported a position in Colgate-Palmolive in Q2 2013 and held it in 22 quarters.
  • Loeb Partners Corp's Colgate-Palmolive position peaked at $3.57M in Q1 2014.
  • 1,446 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2019.

Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.